TRS

TriMas Corporation [TRS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

TRS Stock Summary

Top 10 Correlated ETFs

TRS


Top 10 Correlated Stocks

TRS


In the News

02:11 29 Mar 2024 TRS

Weakness in Specialty Products, High Costs Ail TriMas (TRS)

TriMas' (TRS) results will bear the brunt of the recent weakness in industrial cylinder demand, as well as high costs and labor shortages.

12:50 29 Mar 2024 TRS

TriMas (TRS) Earnings Miss Estimates in Q4, Revenues Rise Y/Y

TriMas' (TRS) Q4 top line reflects organic growth in the aerospace and defense business.

02:00 29 Mar 2024 TRS

TriMas Corporation (TRS) Q4 2023 Earnings Call Transcript

TriMas Corporation (TRS) Q4 2023 Earnings Call Transcript

10:46 29 Mar 2024 TRS

Is TriMas (TRS) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

10:29 29 Mar 2024 TRS

TriMas Announces Fourth Quarter and Full Year 2023 Earnings Conference Call Date

BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--TriMas (NASDAQ: TRS) announced today that it will host its fourth quarter and full year 2023 earnings conference call on Thursday, February 29, 2024. The conference call will begin at 10 a.m. Eastern Time and will follow the Company's release of fourth quarter and full year 2023 earnings results at 8 a.m. that day. To participate on the earnings conference call, please dial: (877) 407-0890 (U.S. and Canada) or +1 (201) 389-0918 (outside the U.S. and Can.

11:16 29 Mar 2024 TRS

5 Metal Fabrication Stocks to Watch in a Challenging Industry

Low order levels cloud the near-term prospects of the Zacks Metal Products - Procurement and Fabrication industry. However, the likes of NHYDY, SKFRY, ESAB, CENX and TRS seem well-poised to tide over the hurdles.

12:02 29 Mar 2024 TRS

TriMas (TRS) Expands Life Sciences' Cleanroom Capabilities

TriMas (TRS) expands the cleanroom capabilities of its Life Sciences division as part of its long-term strategic enhancement.

02:17 29 Mar 2024 TRS

TriMas (TRS) Stock Down 7% in a Year: Will It Bounce Back in 2024?

TriMas' (TRS) results and price performance have been mirroring the persisting weakness in packaging demand, escalating raw material costs and supply-chain constraints.

02:28 29 Mar 2024 TRS

TriMas Corporation (TRS) Q3 2023 Earnings Call Transcript

TriMas Corporation Q3 2023 Results Conference Call October 26, 2023 10:00 AM ET Company Participants Sherry Lauderback - Investor Relations and Communications Thomas Amato - President, CEO and Director Scott Mell - CFO & Principal Accounting Officer Conference Call Participants Hamed Khorsand - BWS Financial Katie Fleischer - KeyBanc Capital Markets Operator Greetings, and welcome to the TriMas Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.

10:33 29 Mar 2024 TRS

TriMas (TRS) Q3 Earnings Surpass Estimates

TriMas (TRS) came out with quarterly earnings of $0.57 per share, beating the Zacks Consensus Estimate of $0.56 per share. This compares to earnings of $0.40 per share a year ago.

TRS Financial details

Company Rating
Buy
Market Cap
1.06B
Income
40.36M
Revenue
893.55M
Book val./share
16.53
Cash/share
0.84
Dividend
0.16
Dividend %
0.65%
Employees
3.4K
Optionable
No
Shortable
Yes
Earnings
25 Apr 2024
P/E
19.84
Forward P/E
12.12
PEG
-5.28
P/S
1.15
P/B
1.51
P/C
31.75
P/FCF
29.52
Quick Ratio
1.27
Current Ratio
2.59
Debt / Equity
0.59
LT Debt / Equity
0.58
-
-
EPS (TTM)
0.98
EPS next Y
2.2
EPS next Q
0.34
EPS this Y
-38.22%
EPS next Y
124.49%
EPS next 5Y
124.49%
EPS last 5Y
-6.67%
Revenue last 5Y
4.31%
Revenue Q/Q
-10.95%
EPS Q/Q
-52.5%
-
-
-
-
SMA20
4%
SMA50
8.33%
SMA100
8.33%
Inst Own
88.52%
Inst Trans
0.89%
ROA
4%
ROE
8%
ROC
0.04%
Gross Margin
23%
Oper. Margin
6%
Profit Margin
6%
Payout
13%
Shs Outstand
41.03M
Shs Float
40.31M
-
-
-
-
Target Price
-
52W Range
22.59-29.07
52W High
-8.03%
52W Low
+21.23%
RSI
69
Rel Volume
0.2
Avg Volume
251.05K
Volume
51.17K
Perf Week
3.57%
Perf Month
5.12%
Perf Quarter
10.89%
Perf Half Y
8.77%
-
-
-
-
Beta
0.691
-
-
Volatility
0.33%, 0.84%
Prev Close
0.72%
Price
26.67
Change
1.95%

TRS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
15.9717.6719.9320.9221.56
Net income per share
1.37-1.831.331.570.97
Operating cash flow per share
1.672.923.121.722.13
Free cash flow per share
1.011.992.070.630.82
Cash per share
3.811.73.272.650.84
Book value per share
15.413.4114.6715.4316.48
Tangible book value per share
4.451.72.762.933.33
Share holders equity per share
15.413.4114.6715.4316.48
Interest debt per share
7.449.1610.710.8410.12
Market cap
1.42B1.38B1.59B1.17B1.05B
Enterprise value
1.57B1.69B1.9B1.5B1.46B
P/E ratio
22.97-17.327.7717.7126.01
Price to sales ratio
1.971.791.861.331.17
POCF ratio
18.8210.8311.8616.1511.91
PFCF ratio
30.9815.8817.8544.0430.9
P/B Ratio
2.042.362.521.81.54
PTB ratio
2.042.362.521.81.54
EV to sales
2.172.22.211.71.63
Enterprise value over EBITDA
11.5817.3213.8211.310.83
EV to operating cash flow
20.8113.2714.1320.7216.54
EV to free cash flow
34.2619.4521.2756.5242.92
Earnings yield
0.04-0.060.040.060.04
Free cash flow yield
0.030.060.060.020.03
Debt to equity
0.460.660.710.680.59
Debt to assets
0.270.320.340.340.3
Net debt to EBITDA
1.113.182.222.493.03
Current ratio
3.622.562.793.022.49
Interest coverage
6.543.266.557.024.84
Income quality
0.77-1.62.341.12.18
Dividend Yield
0000.010.01
Payout ratio
000.030.10.17
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
0.420.430.390.40.41
Capex to operating cash flow
-0.39-0.32-0.34-0.63-0.61
Capex to revenue
-0.04-0.05-0.05-0.05-0.06
Capex to depreciation
-0.68-0.81-0.84-0.86-0.94
Stock based compensation to revenue
0.010.010.010.010.01
Graham number
21.7623.520.9723.3219
ROIC
0.070.040.070.070.05
Return on tangible assets
0.09-0.120.070.090.05
Graham Net
-3.86-8.63-8.41-8.52-10.05
Working capital
314.25M214.64M276.87M282.51M237.93M
Tangible asset value
201.45M74.08M118.63M123.91M138.16M
Net current asset value
-61.18M-257.8M-241.02M-230.51M-261.33M
Invested capital
0.460.660.710.680.59
Average receivables
115.99M111.14M119.52M129M140.2M
Average payables
83.05M71.29M78.86M86.51M88.56M
Average inventory
152.89M141.02M150.92M157.91M177.91M
Days sales outstanding
54.9253.7653.554.6760.47
Days payables outstanding
50.0843.450.0846.0448.01
Days of inventory on hand
91.4292.7486.9688.27100.54
Receivables turnover
6.656.796.826.686.04
Payables turnover
7.298.417.297.937.6
Inventory turnover
3.993.944.24.143.63
ROE
0.09-0.140.090.10.06
Capex per share
-0.65-0.93-1.05-1.09-1.31

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
4.855.195.625.685.07
Net income per share
0.450.120.270.40.19
Operating cash flow per share
0.620.230.40.760.74
Free cash flow per share
0.28-0.120.150.520.27
Cash per share
2.671.251.010.840.84
Book value per share
15.5515.6215.9716.2916.53
Tangible book value per share
2.962.222.633.183.34
Share holders equity per share
15.5515.6215.9716.2916.53
Interest debt per share
10.6810.8311.3310.859.87
Market cap
1.16B1.16B1.14B1.03B1.05B
Enterprise value
1.49B1.55B1.56B1.44B1.46B
P/E ratio
15.4358.9325.8615.5532.96
Price to sales ratio
5.725.374.894.365
POCF ratio
44.83119.4469.0832.6934.22
PFCF ratio
98.43-226.94179.214892.31
P/B Ratio
1.781.781.721.521.53
PTB ratio
1.781.781.721.521.53
EV to sales
7.357.26.716.16.94
Enterprise value over EBITDA
139.1466.6842.7138.3947.17
EV to operating cash flow
57.63160.1394.7745.7747.57
EV to free cash flow
126.54-304.26245.8667.21128.32
Earnings yield
0.0200.010.020.01
Free cash flow yield
0.0100.010.020.01
Debt to equity
0.680.690.70.660.59
Debt to assets
0.340.340.340.330.3
Net debt to EBITDA
30.9116.9411.5810.9813.24
Current ratio
3.022.632.72.592.49
Interest coverage
-0.712.75.056.023.93
Income quality
1.381.971.51.93.85
Dividend Yield
00000
Payout ratio
0.090.340.150.10.21
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
0.40.420.410.40.41
Capex to operating cash flow
-0.54-1.53-0.61-0.32-0.63
Capex to revenue
-0.07-0.07-0.04-0.04-0.09
Capex to depreciation
-1.06-1.11-0.62-0.72-1.38
Stock based compensation to revenue
0.010.010.010.010
Graham number
12.546.449.7712.088.45
ROIC
00.010.010.020.01
Return on tangible assets
0.020.010.010.020.01
Graham Net
-8.59-10.13-10.55-10.06-10.08
Working capital
282.51M242.5M258.32M249.87M237.93M
Tangible asset value
123.91M92.33M108.88M131.7M138.16M
Net current asset value
-230.51M-279.37M-284.06M-259.55M-261.33M
Invested capital
0.680.690.70.660.59
Average receivables
137.49M140.98M157.19M165.31M156.93M
Average payables
89.29M85.49M84.78M82.66M86.72M
Average inventory
168.55M167.56M177.14M182.43M187.39M
Days sales outstanding
58.662.4863.663.4163.57
Days payables outstanding
48.6246.0142.240.949.69
Days of inventory on hand
93.2192.1491.9491.46104.05
Receivables turnover
1.541.441.411.421.42
Payables turnover
1.851.962.132.21.81
Inventory turnover
0.970.980.980.980.87
ROE
0.030.010.020.020.01
Capex per share
-0.34-0.36-0.24-0.24-0.47

TRS Frequently Asked Questions

What is TriMas Corporation stock symbol ?

TriMas Corporation is a US stock , located in Bloomfield hills of Mi and trading under the symbol TRS

What is TriMas Corporation stock quote today ?

TriMas Corporation stock price is $26.67 today.

Is TriMas Corporation stock public?

Yes, TriMas Corporation is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap